The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non–Small Cell Lung Cancer

Published:2017-05-30 Issue:18 Volume:23 Page:5489-5501
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Cascone Tina,Xu Li,Lin Heather Y.,Liu Wenbin,Tran Hai T.,Liu Yuan,Howells Kathryn,Haddad Vincent,Hanrahan Emer,Nilsson Monique B.,Cortez Maria A.,Giri Uma,Kadara Humam,Saigal Babita,Park Yun-Yong,Peng Weiyi,Lee Ju-Seog,Ryan Anderson J.,Jüergensmeier Juliane M.,Herbst Roy S.,Wang Jing,Langley Robert R.,Wistuba Ignacio I.,Lee Jack J.,Heymach John V.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment;International Journal of Molecular Sciences;2024-08-22

2. Pericytes recruited by CCL28 promote vascular normalization after anti-angiogenesis therapy through RA/RXRA/ANGPT1 pathway in lung adenocarcinoma;Journal of Experimental & Clinical Cancer Research;2024-07-29

3. Molecular Mechanisms and Potential Predictive Biomarkers in Advanced Non-small Cell Lung Cancer: A Summary of Current and Future Trends;Archives of Surgery and Clinical Research;2024-06-27

4. Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine;IRAN J BASIC MED SCI;2024

5. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy;Experimental & Molecular Medicine;2023-11-01